Komori
Earnings presentation6521OXIDE CorporationElectrical equipment and precision instruments

Supplementary Explanatory Materials for the Fiscal Year Ending February 2026 Results

For the fiscal year ended February 2026, revenue increased by ¥1,645 million year on year to ¥10,040 million, while operating profit increased by ¥416 million to ¥542 million, resulting in higher revenue and profit. The company outlined a policy of reducing its financial burden by deconsolidating Raicol, while redirecting management resources to growth areas in semiconductors, healthcare and new businesses.

Worth reading
47Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
416
¥ million (year-on-year increase in operating income)
Wording
Conditional
How definitive the wording is.

Contents of this document

Earnings presentationFull fiscal year ended February 20267 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥10,040 million+19.6%
Operating profit¥542 million+330.2%
Operating profit margin5.4 %
Results for the three months of the current quarter
Net Sales
¥3,682 million
Operating profit
¥801 million
Operating profit margin
21.8 %
EBITDA
¥998 million
EBITDA margin
27.1 %
Full-year earnings forecast
Fiscal year ending February 2027
Net Sales
¥9,829 million
Operating profit
¥933 million
Operating profit margin
9.5 %
R&D Expenses
¥1,042 million
EBITDA
¥1,681 million
EBITDA margin
17.1 %
Initial forecast
Net Sales
¥8,713 million
Operating profit
¥409 million
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Significantly exceeded the initial forecast
New initiatives
  • Transfer of all Raicol shares and deconsolidation of Raicol
  • Basic agreement to form a business alliance with Taiwan-based Bolite on semiconductor back-end laser micromachining equipment
  • Launch of sales of ultraviolet laser sources for quantum computers
  • Strategic partnership with Vexlum on high-power lasers for quantum computers
  • Capital investment in growth areas including quantum technologies, data centers, optoelectronic convergence and micromachining
Key KPIsA metric the company considers important as a management benchmark.
  • EBITDA¥1,427 million
    Year on year against the same period last year+281.0%
  • EBITDA margin14.2 %
    Year on year against the same period last year+0.6%
  • Semiconductor business bookings¥5,447 million
  • Semiconductor business order backlog¥3,498 million
  • Semiconductor maintenance revenue¥1,042 million
    Year on year against the same period last yearExceeded ¥1 billion for the first time
  • Net Debt/EBITDA3.7 times
    Year on year against the same period last year-3.4%
  • Debt-to-equity ratio1.6 times
    Year on year against the same period last year-0.3%
  • Equity ratio31.8 %
    Year on year against the same period last year+2.1%
Segment results
  • Semiconductors
    Net Sales¥5,002 million
    Year on year against the same period last year+298.0%
  • Healthcare
    Net Sales¥1,997 million
    Year on year against the same period last year+771.0%
  • New domain
    Net Sales¥3,040 million
    Year on year against the same period last year+575.0%
Medium-term management plan targets
Fiscal year ending February 2029
Net Sales
¥13,000 million
Operating profit margin
14 %
EBITDA margin
23 %
Fiscal year ending February 2028
Operating profit margin
12 %
EBITDA margin
22 %
Orders received and order backlog
Orders received
¥5,447 million
Order backlog
¥3,498 million
Capital expenditures
¥467 million
Contents of this document
ItemDetails
Document typeEarnings presentation
Fiscal Period CoveredFull fiscal year ended February 2026
Net Sales¥10,040 million (YoY +19.6%)
Operating profit¥542 million (YoY +330.2%)
Operating profit margin5.4 %
Results for the three months of the current quarterNet Sales ¥3,682 million / Operating profit ¥801 million / Operating profit margin 21.8 % / EBITDA ¥998 million / EBITDA margin 27.1 %
Full-year earnings forecastFiscal year ending February 2027 Net Sales ¥9,829 million / Operating profit ¥933 million / Operating profit margin 9.5 % / R&D Expenses ¥1,042 million / EBITDA ¥1,681 million / EBITDA margin 17.1 % / Initial forecast Net Sales ¥8,713 million / Operating profit ¥409 million
Self-assessment against the planSignificantly exceeded the initial forecast
Segment resultsSegment Semiconductors / Net Sales ¥5,002 million / Year on year against the same period last year ¥298 million / Profit Not disclosed, Segment Healthcare / Net Sales ¥1,997 million / Year on year against the same period last year ¥771 million / Profit Not disclosed, Segment New domain / Net Sales ¥3,040 million / Year on year against the same period last year ¥575 million / Profit Not disclosed
Key KPIsIndicator name EBITDA / Value ¥1,427 million / Year on year against the same period last year ¥281 million, Indicator name EBITDA margin / Value 14.2 % / Year on year against the same period last year 0.6 %, Indicator name Semiconductor business bookings / Value ¥5,447 million / Year on year against the same period last year Not disclosed, Indicator name Semiconductor business order backlog / Value ¥3,498 million / Year on year against the same period last year Not disclosed, Indicator name Semiconductor maintenance revenue / Value ¥1,042 million / Year on year against the same period last year Exceeded ¥1 billion for the first time, Indicator name Net Debt/EBITDA / Value 3.7 times / Year on year against the same period last year -3.4 times, Indicator name Debt-to-equity ratio / Value 1.6 times / Year on year against the same period last year -0.3 times, Indicator name Equity ratio / Value 31.8 % / Year on year against the same period last year 2.1 %
Medium-term management plan targetsFiscal year ending February 2029 Net Sales ¥13,000 million / Operating profit margin 14 % / EBITDA margin 23 % / Fiscal year ending February 2028 Operating profit margin 12 % / EBITDA margin 22 %
Capital expenditures¥467 million
Orders received and order backlogOrders received ¥5,447 million / Order backlog ¥3,498 million
New initiativesTransfer of all Raicol shares and deconsolidation of Raicol, Basic agreement to form a business alliance with Taiwan-based Bolite on semiconductor back-end laser micromachining equipment, Launch of sales of ultraviolet laser sources for quantum computers, Strategic partnership with Vexlum on high-power lasers for quantum computers, Capital investment in growth areas including quantum technologies, data centers, optoelectronic convergence and micromachining
Items this document does not state (17)
Ordinary incomeNet incomeGross Profit MarginSelling, general and administrative expensesProgress against full-year forecastBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

In semiconductors, results benefited from growing demand for existing products, the launch of new products and commissioned development of next-generation lasers. In new businesses, shipments of Faraday rotators increased against the backdrop of global demand for data centers. The deconsolidation of Raicol also enabled the company to separate factors contributing to deteriorating earnings, reduce debt and improve its equity ratio.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Supplementary Explanatory Materials for the Fiscal Year Ending February 2026 Results | OXIDE Corporation (6521) timely disclosure | Komori